Keywords: EMA, CHMP. Almirall, Constella, Bayer, Eylea, Ironwood Pharma, IBS, Wet-AMD, Regeneron, Macular edema
EMA backs Almirall's Constella; Bayer's Eylea recommended by CHMP
Article | 24 September 2012
The European Medicines Agency last Friday issued a batch of recommendations relating to marketing authorization applications under consideration by the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
